Stock listing
OTC:SEOVF Sernova Biotherapeutics Inc Stock
US listing (OTC) of Sernova Biotherapeutics Inc · home listing TSX:SVA
Follow Sernova Biotherapeutics Inc into a list and get an email when it puts out news.
Share price · OTC:SEOVF
$0.08 USD -0.01 (-11.1%)
Close on Oct 27, 2026
- Day range
- $0.07 – $0.08 USDOct 27, 2026
- Volume
- 28,800 sharesOct 27, 2026
- Market cap
- $30.21M USDAt the close on Oct 27, 2026 · price × 377.6M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:SVA · Home | $0.105 CAD | -0.005 (-4.5%) | 47,270 | $0.105 | $0.105 | $0.105 | $0.110 | Close on Oct 30, 2026 |
| OTC:SEOVF | $0.08 USD | -0.01 (-11.1%) | 28,800 | $0.07 | $0.08 | $0.07 | $0.09 | Close on Oct 27, 2026 |
| Xetra:PSH0 | €0.071 EUR | +0.000 (+0.3%) | 16,855 | €0.071 | €0.077 | €0.062 | €0.071 | Close on Oct 27, 2026 |
- Ticker
- OTC:SEOVF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 19, 2026
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
Latest deck · 2026
Merger or Acquisition (2026)
Merger or acquisition · 16 slides
Latest news
Financings
Convertible notes and common stock purchase warrants of Seraxis
Oct 5, 2026
Closed: US$11.2M raised
Buyers: Dr. Steven Sangha / Arlo Investments; Jonathan Rigby; Will Rust
Insiders: Insiders participated, including Dr. Steven Sangha / Arlo Investments, Sernova management and Seraxis management
Use of proceeds: cGMP manufacturing of SR-02 islet cells and enrollment of T1D patients for the Phase 1/2 clinical trial
Decks
Merger or Acquisition (2026)
Merger or acquisition · 16 slides · 2026
Investor Presentation (February 2025)
Investor deck · 24 slides · February 2025
Investor Presentation (December 2024)
Investor deck · 31 slides · December 2024
Investor Presentation (September 2024)
Investor deck · 21 slides · Sep 12, 2024
Sernova Biotherapeutics Inc on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 165 in all · newest Oct 19, 2026 · oldest 2015
- Decks
- 13 decks · latest 2026
Where Sernova Biotherapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:SVA · Home listing | TSX | Canada | CAD |
| OTC:SEOVF · This page | OTC | United States | USD |
| Xetra:PSH0 | Xetra | Germany | EUR |
| Tradegate:PSH0 | Tradegate | Germany | EUR |
| gettex:PSH0 | gettex | Germany | EUR |
| Cboe Canada:SVA | Cboe Canada | Canada | CAD |
| LS Exchange:A411DW | LS Exchange | Germany | EUR |
| Lang & Schwarz:A411DW | Lang & Schwarz | Germany | EUR |
| Munich:PSH0 | Munich | Germany | EUR |
| Dusseldorf:PSH0 | Dusseldorf | Germany | EUR |
| Hamburg:PSH0 | Hamburg | Germany | EUR |
| Stuttgart:PSH0 | Stuttgart | Germany | EUR |
| Frankfurt:PSH0 | Frankfurt | Germany | EUR |
| Hanover:PSH0 | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Sernova Biotherapeutics Inc.